Cargando…

The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era

Since the late 1990s, tumor necrosis factor alpha (TNF-α) inhibitors (anti-TNFs) have revolutionized the therapy of immune-mediated inflammatory diseases (IMIDs) affecting the gut, joints, skin and eyes. Although the therapeutic armamentarium in IMIDs is being constantly expanded, anti-TNFs remain t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evangelatos, Gerasimos, Bamias, Giorgos, Kitas, George D., Kollias, George, Sfikakis, Petros P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063259/ https://www.ncbi.nlm.nih.gov/pubmed/35503130 http://dx.doi.org/10.1007/s00296-022-05136-x

Ejemplares similares

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols
por: Douni, Eleni, et al.
Publicado: (2004)

Systematic Review with Network Meta-Analysis: Efficacy of Induction Therapy with a Second Biological Agent in Anti-TNF-Experienced Crohn's Disease Patients
por: Pagnini, Cristiano, et al.
Publicado: (2018)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Late-Onset Psoriatic Arthritis: Are There Any Distinct Characteristics? A Retrospective Cohort Data Analysis
por: Gialouri, Chrysoula G., et al.
Publicado: (2023)

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020)

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
por: Kastritis, Efstathios, et al.
Publicado: (2020)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
por: Arida, Aikaterini, et al.
Publicado: (2018)

Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis
por: Armaka, Marietta, et al.
Publicado: (2022)

Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
por: Fragoulis, George E, et al.
Publicado: (2021)

A Critical Role of the p75 Tumor Necrosis Factor Receptor (p75TNF-R) in Organ Inflammation Independent of TNF, Lymphotoxin α, or the p55TNF-R
por: Douni, Eleni, et al.
Publicado: (1998)

Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level: Implications for Pathogenesis and Therapy of Autoimmune Demyelination
por: Kassiotis, George, et al.
Publicado: (2001)

A Case of Microscopic Polyangiitis Presenting as Cranial Giant Cell Arteritis
por: Evangelatos, Gerasimos, et al.
Publicado: (2020)

Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon
por: Protogerou, Athanase D, et al.
Publicado: (2013)

Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study
por: Kougkas, Nikolaos, et al.
Publicado: (2023)

TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity
por: Valatas, Vassilis, et al.
Publicado: (2019)

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
por: Evangelatos, Gerasimos, et al.
Publicado: (2020)

Musculoskeletal Complications of Celiac Disease: A Case-Based Review
por: Evangelatos, Gerasimos, et al.
Publicado: (2023)

Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
por: Ntari, Lydia, et al.
Publicado: (2021)

Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic
por: Fragoulis, George E., et al.
Publicado: (2020)

Intestinal-Specific TNFα Overexpression Induces Crohn’s-Like Ileitis in Mice
por: Bamias, Giorgos, et al.
Publicado: (2013)

Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case report
por: Evangelatos, Gerasimos, et al.
Publicado: (2021)

The second decade
por: Chatterjee, Sandip
Publicado: (2016)

Into the second decade
por: Pines, Jon
Publicado: (2022)

Headache in patients with Paget’s Disease of Bones
por: Evangelatos, Gerasimos, et al.
Publicado: (2017)

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Echocardiography in the Era of COVID-19: Lessons for the Future
por: Medhane, Fitsumberhan, et al.
Publicado: (2021)

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

The Double-Edged Sword of T1-Mapping in Systemic Sclerosis—A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance
por: Markousis-Mavrogenis, George, et al.
Publicado: (2020)

The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study
por: Sandoo, Aamer, et al.
Publicado: (2012)

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
por: Vassilopoulos, Dimitrios, et al.
Publicado: (2020)

Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology
por: Mavrogeni, Sophie I., et al.
Publicado: (2019)

Membrane-Bound TNF Induces Protective Immune Responses to M. bovis BCG Infection: Regulation of memTNF and TNF Receptors Comparing Two memTNF Molecules
por: Olleros, Maria L., et al.
Publicado: (2012)

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis
por: Stavropoulos-Kalinoglou, Antonios, et al.
Publicado: (2012)

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
por: Plasencia, Chamaida, et al.
Publicado: (2013)

Balkan Nephropathy: Evolution of Our Knowledge
por: Bamias, Giorgos, et al.
Publicado: (2008)

Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Sustainable Development under Population Pressure: Lessons from Developed Land Consumption in the Conterminous U.S.
por: Grekousis, George, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lp8ufmvj1nak0njih6jdfu86js